The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 09, 2018

Filed:

Nov. 16, 2015
Applicants:

Vib Vzw, Ghent, BE;

Universiteit Gent, Ghent, BE;

Universiteit Antwerpen, Antwerp, BE;

Inventors:

Peter Vandenabeele, Sint-Amandsberg, BE;

Tom Vanden Berghe, Haasdonk, BE;

Koen Augustyns, Hoogstraten, BE;

Jurgen Joossens, Zoersel, BE;

Pieter Van Der Veken, Sint-Katelijne-Waver, BE;

Sam Hofmans, Willebroek, BE;

Assignees:

VIB VZW, Ghent, BE;

Universiteit Gent, Ghent, BE;

Universiteit Antwerpen, Antwerp, BE;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07C 311/39 (2006.01); C07C 311/40 (2006.01); C07D 295/26 (2006.01); C07D 213/38 (2006.01); C07D 239/26 (2006.01);
U.S. Cl.
CPC ...
C07C 311/39 (2013.01); C07C 311/40 (2013.01); C07D 213/38 (2013.01); C07D 239/26 (2013.01); C07D 295/26 (2013.01); C07C 2601/02 (2017.05); C07C 2601/08 (2017.05); C07C 2601/14 (2017.05); C07C 2601/18 (2017.05); C07C 2602/42 (2017.05); C07C 2603/74 (2017.05);
Abstract

This disclosure relates to a novel class of compounds having the structure of formula I as defined herein and pharmaceutical compositions comprising a compound of formula I or a pharmaceutically acceptable salt thereof. This disclosure also comprises methods of treating a subject by administering a therapeutically effective amount of a compound of formula I or a pharmaceutically acceptable salt thereof to the subject. These compounds are useful for the conditions disclosed herein. This disclosure further comprises methods for making the compounds of formula I and corresponding intermediates.


Find Patent Forward Citations

Loading…